Cryptex Investigación Clínica S.A. de C.V.

Cuauhtémoc, Ciudad de México, Mexico City 06100

0 studies enrolling now · 3 studies all time

What they study most

Atopic Dermatitis, Obesity, Type 2 Diabetes

Studies at this site

• A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity — Running, not enrolling
• A Study of LY3454738 in the Treatment of Adult Participants With Moderate-to-Severe Atopic Dermatitis — Stopped early
• A Study of Orforglipron (LY3502970) Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin — Completed